ClinicalTrials.Veeva
Menu

Find clinical trials for COVID-19 in Paris, Île-de-France

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Infections
Communicable Diseases
Coronavirus Infections
Pneumonia
Post-Acute COVID-19 Syndrome
Human Influenza
Syndrome

COVID-19 trials near Paris, Île-de-France, FRA:

Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 Pneumonia (TRICOVID)

pneumonia (CAP) or moderate / severe Coronavirus Disease 2019 (COVID-19) pneumonia.Other objectives are to determine pharmacokineti...

Enrolling
COVID-19
Bacterial Pneumonia
Drug: Placebo (human albumin 1%)
Drug: Trimodulin

Phase 3

Biotest

Paris, France and 58 other locations

known SARS-CoV-2 variants of concern for pre-exposure prophylaxis of COVID-19.The aim of the Phase I/III study (Parent Study) will -...

Active, not recruiting
COVID-19, SARS-CoV-2
Biological: AZD3152 (Sub-study)
Biological: Placebo (Parent study Sentinel Safety Cohort)

Phase 2, Phase 3

AstraZeneca
AstraZeneca

Paris cedex 10, France and 214 other locations

seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...

Enrolling
COVID-19
Parainfluenza
Drug: DAS181 COVID-19
Drug: DAS181

Phase 3

Ansun Biopharma

Créteil, Ile-de-France, France and 59 other locations

The COVID-19 pandemic is a novel medical challenge, particularly because of the systemic nature of this disease. Indeed, COVID...

Enrolling
SARS-CoV-2 Acute Respiratory Disease
Other: Clinical examination
Other: Olfactory evoked potentials
Pasteur Institute
Pasteur Institute

Paris, France

NEUROCOVID is a prospective multicenter study comparing the proportion of patients with SARS-CoV-2 viral RNA at the level of the olfactory clefts in...

Enrolling
Cognitive Disorder
SARS-CoV-2 Infection
Biological: Nasopharyngeal swab for RT-PCR SARS-CoV-2
Fondation Ophtalmologique Adolphe de Rothschild

Paris, France and 1 other location

One of the current health challenges in the face of the COVID-19 pandemic that started in Wuhan in 2019, and still responsible for ...

Enrolling
COVID-19
Other: Saliva sample collection
Other: Nasopharyngeal and nasal sample collection
Pasteur Institute
Pasteur Institute

Paris, France

Currently, there is no approved treatment for COVID-19 in France, either for the acute phase, nor for the late chronic phase. the i...

Enrolling
SARS-Cov-2 Induced Pulmonary Fibrosis
Drug: Nintedanib 150 MG [Ofev]
Other: Placebo

Phase 3

Assistance Publique - Hôpitaux de Paris

Paris, France

The purpose of the Phase 2 CSEG101B2201 study is to confirm and to establish appropriate dosing and to evaluate the safety in pediatric participants...

Enrolling
Sickle Cell Disease (SCD)
Drug: Crizanlizumab

Phase 2

Novartis
Novartis

Paris 15, France and 56 other locations

Reducing antibiotics prescription is still to date, the main goal in low respiratory tract infections (LRTI).Several studies have shown conflicting r...

Active, not recruiting
Community-acquired Pneumonia
Diagnostic Test: CRP dosage
Diagnostic Test: multiplex PCR
Assistance Publique - Hôpitaux de Paris

Paris, France and 1 other location

The main aim of this study is to check if there are side effects from BAX 888 and to determine the dose of BAX 888 for treating severe hemophilia A i...

Active, not recruiting
Hemophilia A
Drug: BAX 888

Phase 1, Phase 2

Baxalta
Baxalta

Le Kremlin Bicêtre cedex, Val De Marne, France and 25 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems